BE871860A - Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation - Google Patents

Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation

Info

Publication number
BE871860A
BE871860A BE191613A BE191613A BE871860A BE 871860 A BE871860 A BE 871860A BE 191613 A BE191613 A BE 191613A BE 191613 A BE191613 A BE 191613A BE 871860 A BE871860 A BE 871860A
Authority
BE
Belgium
Prior art keywords
infusion
preparation
treatment
solution
hepatic encephalopathy
Prior art date
Application number
BE191613A
Other languages
English (en)
French (fr)
Original Assignee
Leopold & Co Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leopold & Co Chem Pharm filed Critical Leopold & Co Chem Pharm
Publication of BE871860A publication Critical patent/BE871860A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE191613A 1977-11-09 1978-11-08 Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation BE871860A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2750159A DE2750159C3 (de) 1977-11-09 1977-11-09 Infusionslösung zur Behandlung von hepatischer Encephalopathie und ein Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
BE871860A true BE871860A (fr) 1979-05-08

Family

ID=6023374

Family Applications (1)

Application Number Title Priority Date Filing Date
BE191613A BE871860A (fr) 1977-11-09 1978-11-08 Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation

Country Status (11)

Country Link
US (1) US4259353A (ja)
JP (1) JPS5489014A (ja)
BE (1) BE871860A (ja)
CA (1) CA1103160A (ja)
CH (1) CH636766A5 (ja)
DE (1) DE2750159C3 (ja)
FR (1) FR2408347A1 (ja)
GB (1) GB2007503B (ja)
IT (1) IT1108758B (ja)
NL (1) NL7810654A (ja)
SE (1) SE7811446L (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1184499A (en) * 1981-06-29 1985-03-26 David C. Madsen Nutritional composition for management of hepatic failure
US5571783A (en) * 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
WO1996000059A1 (fr) * 1994-06-23 1996-01-04 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique de regenerescence hepatique
US20040022827A1 (en) * 1997-09-30 2004-02-05 Chugai Seiyaku Kabusiki Kaisha Remedy for hepatopathy
WO2010011927A1 (en) 2008-07-25 2010-01-28 Noventis, Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases
AU2011280985C1 (en) 2010-07-22 2016-04-21 Reven Pharmaceuticals, Inc. Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution
JP7142284B2 (ja) * 2017-06-06 2022-09-27 株式会社らいむ 神経伸長促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146166A (en) * 1960-08-26 1964-08-25 Distillers Co Yeast Ltd Cobalamin and amino acid compositions
DK98833C (da) * 1961-04-25 1964-05-25 Novo Terapeutisk Labor As Fremgangsmåde til stabilisering af terapeutisk anvendelige plasminopløsninger.
US3764703A (en) * 1969-11-07 1973-10-09 Astra Ab Amino acid mixture for use in treatment of uremic conditions
US3832465A (en) * 1971-12-09 1974-08-27 H Ghadimi Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
US3950529A (en) * 1975-02-03 1976-04-13 Massachusetts General Hospital Amino acid formulations for patients with liver disease and method of using same
DE2629845A1 (de) * 1976-07-02 1978-01-05 Geb Graze Erika Graze Infusions- bzw. injektionsloesungen bzw. waessrige konzentrate zu deren bereitung zur therapeutischen restituion des zellulaeren energiestoffwechsels und der koerpereigenen regelfunktion

Also Published As

Publication number Publication date
FR2408347B1 (ja) 1981-06-26
IT7869444A0 (it) 1978-10-24
GB2007503B (en) 1982-03-17
SE7811446L (sv) 1979-05-10
DE2750159A1 (de) 1979-05-10
CA1103160A (en) 1981-06-16
NL7810654A (nl) 1979-05-11
GB2007503A (en) 1979-05-23
IT1108758B (it) 1985-12-09
CH636766A5 (de) 1983-06-30
JPS5729446B2 (ja) 1982-06-23
DE2750159C3 (de) 1980-05-22
US4259353A (en) 1981-03-31
DE2750159B2 (de) 1979-09-06
FR2408347A1 (fr) 1979-06-08
JPS5489014A (en) 1979-07-14

Similar Documents

Publication Publication Date Title
BE849218A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
BE860712A (fr) Polyurethannes dispersables dans l'eau et leur procede de preparation
BE870055A (fr) Compositions et procede pour le traitement des calculs renaux
MA18939A1 (fr) Procede de preparation d'un agent pour le traitement de theilerioses
RO76054A (ro) Procedeu pentru prepararea unor tetradecapeptide
BE876157Q (fr) Medicament pour le traitement de l'acne
BE866841A (fr) Procede de preparation d'imidazoazines et -diazines substituees et leur utilisation
BE844825A (fr) Procede de traitement pour combattre l'endotoxemie
RO81474A (ro) Procedeu pentru prepararea interferonei omogene din fibroplaste umane
BE867952A (fr) Procede et reactif pour le dosage de l'acide ascorbique
RO79398A (ro) Procedeu pentru prepararea unor 1-oxa-detiacefalosporine
BE871860A (fr) Solution pour infusion pour le traitement de l'encephalopathie hepatique et procede pour sa preparation
BE872294A (fr) Procede de preparation de 3-iodorifamycine s et de 3-bromorifamycine s
BE858806A (fr) Procede pour la preparation de glycol-aldehyde et d'ethylene-glycol
RO78342A (ro) Procedeu de preparare a unor imino-eteri de benztiazoline si benzoxazoline
BE864002A (fr) Procede pour la preparation de mefloquine
BE865480A (fr) Procede pour la preparation d'acides naphtylaminohydroxysulfoniques
BE867414A (fr) Procede pour la preparation d'hydroxy-alpha-aminobenzylpenicillines
BE867228A (fr) Procede pour la preparation d'hydroxyphenylglycocolles
RO76126A2 (ro) Procedeu pentru prepararea acizilor antrachinon 2,6-si-2,7-disulfonici
RO75072A (ro) Procedeu pentru prepararea unor anilide ale acizilor ciclopropancarboxilici
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
BE874547A (fr) Procede perfectionne pour la preparation d'organo-thioaldoximes
FR2313336A2 (fr) Procede pour la preparation de cycloalcanones et cycloalcanols
RO65965A2 (ro) Compozitie medicamentoasa pentru tratamentul ulcerului gastroduodenal

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LEOPOLD PHARMA G.M.B.H.

Effective date: 19911130